Does Alzheimer's disease protect against cancers? A nationwide population-based study

Neuroepidemiology

Volumn 40, Issue 1, 2012, Pages 42-49

  Ou, Shuo Ming ^a   Lee, Yi Jung ^b,h   Hu, Yu Wen ^c,h   Liu, Chia Jen ^d,h   Chen, Tzeng Ji ^e,h   Fuh, Jong Ling ^f,h   Wang, Shuu Jiun ^f,g,h  

^a Division of Nephrology   (Taiwan)

^b Neurological Institute   (Taiwan)

^c Cancer Center   (Taiwan)

^d Division of Hematology and Oncology   (Taiwan)

^e Taipei Veterans General Hospital ^*  (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g Institute of Brain Science   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Cancer; Epidemiology; Risk factors

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BILIARY TRACT CANCER; BLADDER CANCER; BONE CANCER; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; ESOPHAGUS CANCER; FEMALE; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; RISK REDUCTION; SKIN CANCER; SOFT TISSUE CANCER; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; TAIWAN; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84867458469     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000341411     Document Type: Article

References (42)

1. Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW: Cancer and neurodegenera-tion: between the devil and the deep blue sea. PLoS Genet 2010; 6:e1001257.
2. Tavares AR Jr, de Melo AC, Sternberg C: Cancer linked to Alzheimer disease but not vascu lar dementia. Neurology 2010; 75: 1215-1216;author reply 1216.
3. Hoskin DW, Ramamoorthy A: Studies on anticancer activities of antimicrobial pep-tides. Biochim Biophys Acta 2008; 1778:357-375.
4. Schuller HM: Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 2009; 9: 195-205.
5. Burke WJ, McLaughlin JR, Chung HD, Gil-lespie KN, Grossberg GT, Luque FA, Zimmerman J: Occurrence of cancer in Alzheimer and elderly control patients: an epide-miologic necropsy study. Alzheimer Dis Assoc Disord 1994; 8:22-28.
6. Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, Williams MM, Kopan R, Behrens MI, Morris JC: Cancer linked to Alz heimer disease but not vascular dementia. Neurology 2010; 74: 106-112.
7. Lin HP, Deng CY, Chou P: Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the taiwan reporting enquiry system, 2002-2006. BMC Public Hea lth 2009; 9: 55.
8. Liu CJ, Chang YS, Teng CJ, Chen TJ, Ou SM, Tzeng CH, Wang SJ: Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study. Eur J Neurol 2012; 19: 746-751.
9. Tsan YT, Lee CH, Wang JD, Chen PC: Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012; 30: 623-630.
10. Inzelberg R, Jankovic J: Are Parkinson disease patients protected from some but not all cancers? Neurology 2007; 69:1542-1550.
11. Moller H, Mellemkjaer L, McLaughlin JK, Olsen JH: Occurrence of different cancers in patients with Parkinson's disease. BMJ 1995; 310: 1500-1501.
12. Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T: A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Bio-markers Prev 2007; 16:1260-1265.
13. Sorensen SA, Fenger K, Olsen JH: Significantly lower incidence of cancer among patients w it h Hu nt ing ton disease: a n apoptot ic effect of an expanded polyglutamine tract? Cancer 1999; 86: 1342-1346.
14. Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ: Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies. J Neurol Neurosurg Psychiatry 2010; 81: 215-221.
15. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr: Cancer statistics by race and ethnicity. CA Cancer J Clin 1998; 48:31-48.
16. Yin D, Morris C, Allen M, Cress R, Bates J, Liu L: Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups? Cancer Causes Control 2010; 21: 1721-1730.
17. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
18. Pollard JW, Pacey J, Cheng SV, Jordan EG: Estrogens and cell death in murine uterine luminal epithelium. Cell Tissue Res 1987; 249: 533-540.
19. Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 1991; 51: 162-166.
20. Mohamd EM, Ahmed HH, Estefan SF, Far-rag AE, Salah RS: Windows into estradiol effects in Alzheimer's disease therapy. Eur Rev Med Pharmacol Sci 2011; 15:1131-1140.
21. Lewis-Wambi JS, Jordan VC: Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res 2009; 11: 206.
22. Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M, Mayeux R: Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 2000; 54: 833-837.
23. Barrett-Connor E, Laughlin GA: Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials. Semin Reprod Med 2009; 27:275-282.
24. Allam MF, Campbell MJ, Hofman A, Del Castillo AS, Fernandez-Crehuet Navajas R: Smoking and Parkinson's disease: systematic review of prospective studies. Mov Disord 2004; 19: 614-621.
25. Anstey KJ, von Sanden C, Salim A, O'Kearney R: Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166: 367-378.
26. Tsai YW, Tsai TI, Yang CL, Kuo KN: Gender differences in smoking behaviors in an Asian population. J Womens Health (Larchmt) 2008; 17:971-978.
27. Rostami-Hodjegan A, Lennard MS, Woods HF, Tucker GT: Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease. Phar-macogenetics 1998; 8: 227-238.
28. Golab-Janowska M, Honczarenko K, Gawronska-Szklarz B, Potemkowski A: CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Park in s on's d isease w it h dement ia. Ne u rol Neu-rochir Pol 2007; 41:113-121.
29. Sober AJ, Wick MM: Levodopa therapy and ma lignant melanoma. JAMA 1978; 240: 554-555.
30. Sandyk R: Accelerated growth of malignant melanoma by levodopa in Parkinson's disease and role of the pineal gland. Int J Neu-rosci 1992; 63:137-140.
31. Fiala KH, Whetteckey J, Manyam BV: Malignant melanoma and levodopa in Park inson's disease: causality or coincidence? Parkin-sonism Relat Disord 2003; 9: 321-327.
32. Bellew S, Del Rosso JQ, Kim GK: Skin cancer in Asians. 2. Melanoma. J Clin Aesthet Der-matol 2009; 2:34-36.
33. Shoo BA, Kashani-Sabet M: Melanoma arising in African-, Asian-, Latino-and Native-American populations. Semin Cutan Med Surg 2009; 28:96-102.
34. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA: Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 2011; 106: 1911-1921;qu iz 1922.
35. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z: Diabetes mellitus a nd risk of pancreatic cancer: a meta-analysis of co-hor t studies. Eur J Cancer 2011; 47: 1928-1937.
36. Noto H, Tsujimoto T, Sasazuki T, Noda M: Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 2011; 17:616-628.
37. Wong G, Howard K, Tong A, Craig JC: Cancer screening in people who have chronic disease: the example of kidney disease. Semin Dial 2011; 24:72-78.
38. Kornum JB, Svaerke C, Thomsen RW, Lange P, Sorensen HT: Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study. Respir Med 2012; 106: 845-852.
39. Gayed M, Bernatsky S, Ramsey-Goldman R, Clarke A, Gordon C: Lupus and cancer. Lupus 2009; 18: 479-485.
40. Barnes J, Mayes MD: Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 2012; 24: 165-170.
41. Chuang WL, Yu ML, Dai CY, Chang WY: Treatment of chronic hepatitis C in southern Taiwan. Intervirology 2006; 49:99-106.
42. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ: Epide-miological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996; 117:313-325.